Utility of circulating tumor DNA (ctDNA) as a predictive biomarker for disease monitoring in patients with non-seminomatous germ-cell tumor (NSGCT).
| Autor: | Hassoun, Rebecca, Cary, Clint, Masterson, Timothy A., Laliotis, George, Sharma, Shruti, Dutta, Punashi, Malhotra, Meenakshi, ElNaggar, Adam, Liu, Minetta C., Sfakianos, John P., King, Jennifer, Einhorn, Lawrence H., Adra, Nabil |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p500-500, 25p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|